ACP-105 is a compound created
in the laboratories of the Swedish company Acadia Pharmaceuticals in 2009, and has been the subject of numerous studies highlighting its properties and potential applications.
Specifically, ACP-105 binds to the androgen receptor more effectively than DHT, suggesting its potential efficacy as a SARM (Selective Androgen Receptor Modulator).
ACP-105 is a type of SARM (Selective Androgen Receptor Modulator) that has been developed to help build muscle mass and improve athletic performance.
SARMS are a type of synthetic compound that selectively binds to androgen receptors in the body, but with fewer side effects than anabolic steroids.
In particular, ACP-105 has been studied for its ability to increase bone density and muscle mass.
This compound has also been shown to increase muscle strength and endurance, making it attractive to athletes and bodybuilders seeking a competitive edge.
A study in mice has shown that the use of ACP-105 can significantly increase muscle mass and bone density without causing significant side effects. However, it is important to note that the effects on mice may not be directly transferable to humans.
As we mentioned, ACP-105 was originally created to help individuals with degenerative bone disorders.
Because of its ability to increase muscle mass and strength, it has become a product of great interest to the bodybuilding world.
ACP-105 helps increase lean muscle mass, strength, and endurance quickly and effectively.
It has been shown to have a number of interesting properties, including:
- Significant increase in muscle mass (noticeable within the first week of use).
- Increased strength and endurance.
- Rapid and effective healing from injury or overexertion.
- Improved cognitive ability and memory due to increased androgen receptors in the brain.
- Reduction of muscle catabolism.
- Promotes energy utilization of fat mass.
- Reduction of water retention.
- Significant lipolytic properties.
One of the major benefits that many users tend to experience is increased strength, which can reach an average increase of 20% to 30% during a cycle of ACP-105.
In addition, ACP-105 has been shown to promote body fat loss, making it a perfect product for the cutting or body recomposition phase.
However, as with any supplement or medication, the use of ACP-105 can cause some side effects such as headaches, fatigue, and nausea.
Also, in some cases, it may cause testosterone suppression.
Side effects are generally rare and not serious.
ACP-105 can be administered orally and has been shown to be effective as SARM based on animal studies.
In particular, one study showed its strong anabolic effect with a 67% reversal of ORX-induced atrophy at 1 mg/kg/day, but minor androgenic effects on the prostate, with a 21% reversal of T, 48%.
These results suggest the potential efficacy of this compound in the prevention and treatment of muscle atrophy.
In addition, animal studies indicated that ACP-105 might offer some protection against the effects of nuclear radiation.
This finding is particularly interesting in view of the potential application of this compound in the protection of tissues and organs exposed to radiation, such as in medical or military settings.
Despite these promising results, it is important to note that studies on ACP-105 are still in the preclinical stage and that further research is needed to evaluate its efficacy and safety in humans.
However, the growing interest and recent developments related to this compound indicate that it could be a promising area of future research.
Regarding the cycle of ACP-105, there is no established dose, but there is anecdotal evidence from users that can help get an idea of how to use the product.
A standard cycle of ACP-105 for the average male user is said to be 10 to 15 mg daily for 8 to 12 weeks, divided into two daily doses because of the molecule’s half-life of about 8 hours.
At the end of the cycle, post cycle therapy (PCT) with Enclomiphene is required.
For ACP-105, we have collected some reviews from users in our Telegram group that can help you make a more informed decision.
One of the users wrote:
“Zero side effects, strength gains were better than I expected considering I was in a significant caloric deficit.
I did not experience any water retention. It is probably the best cutting product I have ever used. No side effects detected.”
Another user compared ACP-105 with Ostarine:
“In my experience, ACP was more suppressive than Osta, but on the other hand, ACP had a much smaller impact on lipids and liver enzymes. Osta on the other hand was much heavier on lipids and liver for me.”
A third user stated:
“ACP105 beats Ostarin in my experience. The only downside is that it is a little more suppressive.”
These reviews suggest that ACP-105 is one of the most effective SARMs available on the market with fewer side effects.
It is important to note that user reviews represent only a personal opinion and that results may vary from person to person.
In conclusion, ACP-105 is a promising SARM with numerous benefits for improving athletic performance and body composition.
